317 related articles for article (PubMed ID: 17992275)
1. Metal based drugs: from serendipity to design.
Fricker SP
Dalton Trans; 2007 Nov; (43):4903-17. PubMed ID: 17992275
[TBL] [Abstract][Full Text] [Related]
2. Cysteine proteases as targets for metal-based drugs.
Fricker SP
Metallomics; 2010 Jun; 2(6):366-77. PubMed ID: 21072382
[TBL] [Abstract][Full Text] [Related]
3. A categorization of metal anticancer compounds based on their mode of action.
Gianferrara T; Bratsos I; Alessio E
Dalton Trans; 2009 Oct; (37):7588-98. PubMed ID: 19759927
[TBL] [Abstract][Full Text] [Related]
4. Targeted therapy vs. DNA-adduct formation-guided design: thoughts about the future of metal-based anticancer drugs.
Sava G; Jaouen G; Hillard EA; Bergamo A
Dalton Trans; 2012 Jul; 41(27):8226-34. PubMed ID: 22614531
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450s in the development of target-based anticancer drugs.
Purnapatre K; Khattar SK; Saini KS
Cancer Lett; 2008 Jan; 259(1):1-15. PubMed ID: 18053638
[TBL] [Abstract][Full Text] [Related]
6. Modeling anticancer drug-DNA interactions via mixed QM/MM molecular dynamics simulations.
Spiegel K; Magistrato A
Org Biomol Chem; 2006 Jul; 4(13):2507-17. PubMed ID: 16791311
[TBL] [Abstract][Full Text] [Related]
7. Chemical approaches to the discovery and development of cancer therapies.
Neidle S; Thurston DE
Nat Rev Cancer; 2005 Apr; 5(4):285-96. PubMed ID: 15803155
[TBL] [Abstract][Full Text] [Related]
8. Exploring biologically relevant chemical space with metal complexes.
Meggers E
Curr Opin Chem Biol; 2007 Jun; 11(3):287-92. PubMed ID: 17548234
[TBL] [Abstract][Full Text] [Related]
9. Bioactive luminescent transition-metal complexes for biomedical applications.
Ma DL; He HZ; Leung KH; Chan DS; Leung CH
Angew Chem Int Ed Engl; 2013 Jul; 52(30):7666-82. PubMed ID: 23765907
[TBL] [Abstract][Full Text] [Related]
10. Opportunities and challenges in the discovery of new central nervous system drugs.
Krause JE; Chenard BL
Ann N Y Acad Sci; 2008 Nov; 1144():243-50. PubMed ID: 19076381
[TBL] [Abstract][Full Text] [Related]
11. Metal-based antitumour drugs in the post-genomic era: what comes next?
Sava G; Bergamo A; Dyson PJ
Dalton Trans; 2011 Sep; 40(36):9069-75. PubMed ID: 21725573
[TBL] [Abstract][Full Text] [Related]
12. Medicinal organometallic chemistry: designing metal arene complexes as anticancer agents.
Peacock AF; Sadler PJ
Chem Asian J; 2008 Nov; 3(11):1890-9. PubMed ID: 18712745
[TBL] [Abstract][Full Text] [Related]
13. [Application of metal ions and their complexes in medicine II. Application of platina complexes in the treatment of tumor].
Nagy L; Csintalan G; Kálmán E; Nagy E; Sipos P
Acta Pharm Hung; 2004; 74(4):213-22. PubMed ID: 16316049
[TBL] [Abstract][Full Text] [Related]
14. DNA as a target for anticancer compounds: methods to determine the mode of binding and the mechanism of action.
Palchaudhuri R; Hergenrother PJ
Curr Opin Biotechnol; 2007 Dec; 18(6):497-503. PubMed ID: 17988854
[TBL] [Abstract][Full Text] [Related]
15. Hybrid molecules with a dual mode of action: dream or reality?
Meunier B
Acc Chem Res; 2008 Jan; 41(1):69-77. PubMed ID: 17665872
[TBL] [Abstract][Full Text] [Related]
16. Novel metal-based anticancer drugs: a new challenge in drug delivery.
Lainé AL; Passirani C
Curr Opin Pharmacol; 2012 Aug; 12(4):420-6. PubMed ID: 22609113
[TBL] [Abstract][Full Text] [Related]
17. Network pharmacology: the next paradigm in drug discovery.
Hopkins AL
Nat Chem Biol; 2008 Nov; 4(11):682-90. PubMed ID: 18936753
[TBL] [Abstract][Full Text] [Related]
18. Towards the rational design of platinum(II) and gold(III) complexes as antitumour agents.
Wang X; Guo Z
Dalton Trans; 2008 Mar; (12):1521-32. PubMed ID: 18335133
[TBL] [Abstract][Full Text] [Related]
19. Recent researches in metal supramolecular complexes as anticancer agents.
Zhou CH; Zhang YY; Yan CY; Wan K; Gan LL; Shi Y
Anticancer Agents Med Chem; 2010 Jun; 10(5):371-95. PubMed ID: 20380632
[TBL] [Abstract][Full Text] [Related]
20. CE in anticancer metallodrug research--an update.
Hartinger CG; Keppler BK
Electrophoresis; 2007 Oct; 28(19):3436-46. PubMed ID: 17847132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
